IMMUNEVAX Trademark

Trademark Overview

On Friday, September 26, 2025, a trademark application was filed for IMMUNEVAX with the United States Patent and Trademark Office. The USPTO has given the IMMUNEVAX trademark a serial number of 99413961. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, September 26, 2025. The IMMUNEVAX trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
immunevax

General Information

Serial Number99413961
Word MarkIMMUNEVAX
Filing DateFriday, September 26, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, September 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkIMMUNE VAX
Goods and ServicesBusiness consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, September 26, 2025
Primary Code035
First Use Anywhere DateFriday, July 17, 2009
First Use In Commerce DateFriday, July 17, 2009

Trademark Owner History

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMarietta, GA 30066

Trademark Events

Event DateEvent Description
Friday, September 26, 2025NEW APPLICATION ENTERED
Friday, September 26, 2025APPLICATION FILING RECEIPT MAILED
Saturday, September 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

immunevax clinical management trials assist companies biotechnology them research approval biopharmaceutical